449 related articles for article (PubMed ID: 24461612)
1. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial.
Page VJ; Ely EW; Gates S; Zhao XB; Alce T; Shintani A; Jackson J; Perkins GD; McAuley DF
Lancet Respir Med; 2013 Sep; 1(7):515-23. PubMed ID: 24461612
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of early administration of simvastatin in the prevention and treatment of delirium in critically ill patients undergoing mechanical ventilation (MoDUS): a randomised, double-blind, placebo-controlled trial.
Page VJ; Casarin A; Ely EW; Zhao XB; McDowell C; Murphy L; McAuley DF
Lancet Respir Med; 2017 Sep; 5(9):727-737. PubMed ID: 28734823
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of halopeRIdol to decrease the burden of Delirium In adult Critically ill patiEnts (EuRIDICE): study protocol for a prospective randomised multi-centre double-blind placebo-controlled clinical trial in the Netherlands.
Smit L; Trogrlić Z; Devlin JW; Osse RJ; Ponssen HH; Slooter AJC; Hunfeld NGM; Rietdijk WJR; Gommers D; van der Jagt M;
BMJ Open; 2020 Sep; 10(9):e036735. PubMed ID: 32967873
[TBL] [Abstract][Full Text] [Related]
4. Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low-Dose IV Haloperidol: A Double-Blind, Placebo-Controlled Pilot Study.
Al-Qadheeb NS; Skrobik Y; Schumaker G; Pacheco MN; Roberts RJ; Ruthazer RR; Devlin JW
Crit Care Med; 2016 Mar; 44(3):583-91. PubMed ID: 26540397
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of haloperidol to decrease the burden of delirium in adult critically ill patients: the EuRIDICE randomized clinical trial.
Smit L; Slooter AJC; Devlin JW; Trogrlic Z; Hunfeld NGM; Osse RJ; Ponssen HH; Brouwers AJBW; Schoonderbeek JF; Simons KS; van den Boogaard M; Lens JA; Boer DP; Gommers DAMPJ; Rietdijk WJR; van der Jagt M;
Crit Care; 2023 Oct; 27(1):413. PubMed ID: 37904241
[TBL] [Abstract][Full Text] [Related]
6. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.
van Eijk MM; Roes KC; Honing ML; Kuiper MA; Karakus A; van der Jagt M; Spronk PE; van Gool WA; van der Mast RC; Kesecioglu J; Slooter AJ
Lancet; 2010 Nov; 376(9755):1829-37. PubMed ID: 21056464
[TBL] [Abstract][Full Text] [Related]
7. Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium: The REDUCE Randomized Clinical Trial.
van den Boogaard M; Slooter AJC; Brüggemann RJM; Schoonhoven L; Beishuizen A; Vermeijden JW; Pretorius D; de Koning J; Simons KS; Dennesen PJW; Van der Voort PHJ; Houterman S; van der Hoeven JG; Pickkers P; ; van der Woude MCE; Besselink A; Hofstra LS; Spronk PE; van den Bergh W; Donker DW; Fuchs M; Karakus A; Koeman M; van Duijnhoven M; Hannink G
JAMA; 2018 Feb; 319(7):680-690. PubMed ID: 29466591
[TBL] [Abstract][Full Text] [Related]
8. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness.
Girard TD; Exline MC; Carson SS; Hough CL; Rock P; Gong MN; Douglas IS; Malhotra A; Owens RL; Feinstein DJ; Khan B; Pisani MA; Hyzy RC; Schmidt GA; Schweickert WD; Hite RD; Bowton DL; Masica AL; Thompson JL; Chandrasekhar R; Pun BT; Strength C; Boehm LM; Jackson JC; Pandharipande PP; Brummel NE; Hughes CG; Patel MB; Stollings JL; Bernard GR; Dittus RS; Ely EW;
N Engl J Med; 2018 Dec; 379(26):2506-2516. PubMed ID: 30346242
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Management of Delirium in the Intensive Care Unit: A Randomized Pragmatic Clinical Trial.
Khan BA; Perkins AJ; Campbell NL; Gao S; Farber MO; Wang S; Khan SH; Zarzaur BL; Boustani MA
J Am Geriatr Soc; 2019 May; 67(5):1057-1065. PubMed ID: 30681720
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological interventions for the treatment of delirium in critically ill adults.
Burry L; Hutton B; Williamson DR; Mehta S; Adhikari NK; Cheng W; Ely EW; Egerod I; Fergusson DA; Rose L
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011749. PubMed ID: 31479532
[TBL] [Abstract][Full Text] [Related]
11. Interventions for preventing intensive care unit delirium in adults.
Herling SF; Greve IE; Vasilevskis EE; Egerod I; Bekker Mortensen C; Møller AM; Svenningsen H; Thomsen T
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD009783. PubMed ID: 30484283
[TBL] [Abstract][Full Text] [Related]
12. Association Between Incident Delirium Treatment With Haloperidol and Mortality in Critically Ill Adults.
Duprey MS; Devlin JW; van der Hoeven JG; Pickkers P; Briesacher BA; Saczynski JS; Griffith JL; van den Boogaard M
Crit Care Med; 2021 Aug; 49(8):1303-1311. PubMed ID: 33861548
[TBL] [Abstract][Full Text] [Related]
13. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial.
Girard TD; Pandharipande PP; Carson SS; Schmidt GA; Wright PE; Canonico AE; Pun BT; Thompson JL; Shintani AK; Meltzer HY; Bernard GR; Dittus RS; Ely EW;
Crit Care Med; 2010 Feb; 38(2):428-37. PubMed ID: 20095068
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Haloperidol Effects on Long-term Quality of Life in Critically Ill Patients at High Risk for Delirium: Results of the REDUCE Study.
Rood PJT; Zegers M; Slooter AJC; Beishuizen A; Simons KS; van der Voort PHJ; van der Woude MCE; Spronk PE; van der Hoeven JG; Pickkers P; van den Boogaard M
Anesthesiology; 2019 Aug; 131(2):328-335. PubMed ID: 31246603
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
16. Association between incident delirium and 28- and 90-day mortality in critically ill adults: a secondary analysis.
Duprey MS; van den Boogaard M; van der Hoeven JG; Pickkers P; Briesacher BA; Saczynski JS; Griffith JL; Devlin JW
Crit Care; 2020 Apr; 24(1):161. PubMed ID: 32312288
[TBL] [Abstract][Full Text] [Related]
17. Agents intervening against delirium in the intensive care unit (AID-ICU) - Protocol for a randomised placebo-controlled trial of haloperidol in patients with delirium in the ICU.
Andersen-Ranberg NC; Poulsen LM; Perner A; Wetterslev J; Estrup S; Lange T; Ebdrup BH; Hästbacka J; Morgan MPG; Citerio G; Zafrani L; Caballero J; Oxenbøll-Collet M; Weber SO; Andreasen AS; Bestle M; Pedersen HBS; Hildebrandt T; Thee C; Jensen TB; Dey N; Nielsen LG; Mathiesen O
Acta Anaesthesiol Scand; 2019 Nov; 63(10):1426-1433. PubMed ID: 31350916
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study.
Devlin JW; Roberts RJ; Fong JJ; Skrobik Y; Riker RR; Hill NS; Robbins T; Garpestad E
Crit Care Med; 2010 Feb; 38(2):419-27. PubMed ID: 19915454
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial.
Su X; Meng ZT; Wu XH; Cui F; Li HL; Wang DX; Zhu X; Zhu SN; Maze M; Ma D
Lancet; 2016 Oct; 388(10054):1893-1902. PubMed ID: 27542303
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study.
Pun BT; Badenes R; Heras La Calle G; Orun OM; Chen W; Raman R; Simpson BK; Wilson-Linville S; Hinojal Olmedillo B; Vallejo de la Cueva A; van der Jagt M; Navarro Casado R; Leal Sanz P; Orhun G; Ferrer Gómez C; Núñez Vázquez K; Piñeiro Otero P; Taccone FS; Gallego Curto E; Caricato A; Woien H; Lacave G; O'Neal HR; Peterson SJ; Brummel NE; Girard TD; Ely EW; Pandharipande PP;
Lancet Respir Med; 2021 Mar; 9(3):239-250. PubMed ID: 33428871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
